Prescription for treating prostatitis and other reproductive system diseases of male

Abstract

The invention relates to a formula for treating prostatitis and other male reproductive system diseases. The invention discloses a main compound extracted from mangosteen: Garcinia Mangostana, wherein alpha-mangostin is taken as a main effective constituent and mixed with various commonly used fillers in the medicine industry to prepare various appropriate preparation formulations including tablets, capsules, powder, and suppository; and the various preparation formulations can be used for preventing and treating male reproductive system inflammations such as prostatitis, orchitis, deferentitis and urethritis by means of oral taking or external application. The content of the alpha-mangostin in the product is between 3 and 99.8 percent; and the prepared product can relieve various inflammations, has the function of relieving pain to certain degree, and can be independently used or mixed with other natural substances for use.

Description

Technical field: [0001] Prostatitis is a common disease in adult males, accounting for about 25% to 30% of outpatient diseases in urology department according to general statistics. Infect. Acute prostatitis mostly has a sudden onset, with symptoms such as frequent urination, urgency, and painful urination. Chronic prostatitis is not so simple. It has many symptoms, mainly pain or discomfort, and sometimes urinary tract irritation symptoms. Severe prostatitis Inflammation patients also have symptoms such as lack of energy, fatigue, dizziness and tinnitus. [0002] Currently, for the treatment of prostatitis and other male reproductive system diseases, commonly used non-steroidal (non-steroidal) anti-inflammatory drugs (NSAIDs) have side effects to varying degrees. The most common adverse reactions of NSAIDs include gastrointestinal damage, liver and kidney damage, effects on the blood system, symptoms of the central nervous system, and allergic reactions. Gastrointestinal r...

AI Technical Summary

Problems solved by technology

Toxicology research experiments have proved that in the acute toxicity experiment, we increased the dosage to the most concentrated level (400 times the human dosage) and still did not measure the lethal dose (LD50), which proved to be extremely safe; There is no report on the interaction between α-pandrostin and other drugs